Long-Term Follow up for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Tyrosine kinase inhibitors (TKIs) have improved the outcomes of patients with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Many older patients (pts) are not good candidates for intensive chemotherapy and are treated with TKIs plus corticosteroids or low-intensity chemot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2023-11, Vol.142 (Supplement 1), p.1499-1499
Hauptverfasser: Advani, Anjali S., Moseley, Anna B, O'Dwyer, Kristen M., Wood, Brent L., Park, Jae H., Wieduwilt, Matthew J., Jeyakumar, Deepa, Yaghmour, George, Atallah, Ehab L., Gerds, Aaron T., O'Brien, Susan M., Liesveld, Jane L., Othus, Megan, Litzow, Mark R., Stone, Richard M, Sharon, Elad, Yeung, Cecilia C.S., Radich, Jerald P., Erba, Harry P.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!